Chanley Howell Weighs in on FTC’s Impersonation Rule, Fight Against AI Powered Fraud
08 April 2024
Foley & Lardner LLP partner Chanley Howell joined the Information Week panel discussion, “FTC’s Impersonation Rule and the Fight Against AI-Powered Fraud,” to assess the U.S. Federal Trade Commission’s new rule targeting impersonation fraud.
“While the rule is not limited to AI, it was a clear motivating factor behind the rule,” Howell explained. “It’s another brick in the wall of building the laws that relate to AI.”
Howell said he views the rule as a net positive as it offers additional guidance on how best to advise clients, though he cautioned that as the rule increases the visibility of this issue, companies will need to stay aware of their potential liabilities.
To see a video recording of the panel discussion, click here.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”